BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15808751)

  • 1. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
    Kastrup J; Jørgensen E; Rück A; Tägil K; Glogar D; Ruzyllo W; Bøtker HE; Dudek D; Drvota V; Hesse B; Thuesen L; Blomberg P; Gyöngyösi M; Sylvén C;
    J Am Coll Cardiol; 2005 Apr; 45(7):982-8. PubMed ID: 15808751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.
    Gyöngyösi M; Khorsand A; Zamini S; Sperker W; Strehblow C; Kastrup J; Jorgensen E; Hesse B; Tägil K; Bøtker HE; Ruzyllo W; Teresiñska A; Dudek D; Hubalewska A; Rück A; Nielsen SS; Graf S; Mundigler G; Novak J; Sochor H; Maurer G; Glogar D; Sylven C
    Circulation; 2005 Aug; 112(9 Suppl):I157-65. PubMed ID: 16159809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD).
    Kukuła K; Chojnowska L; Dąbrowski M; Witkowski A; Chmielak Z; Skwarek M; Kądziela J; Teresińska A; Małecki M; Janik P; Lewandowski Z; Kłopotowski M; Wnuk J; Rużyłło W
    Am Heart J; 2011 Mar; 161(3):581-9. PubMed ID: 21392615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial.
    Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A165 plasmid in patients with inoperable angina pectoris.
    Sylvén C; Sarkar N; Rück A; Drvota V; Hassan SY; Lind B; Nygren A; Källner Q; Blomberg P; van der Linden J; Lindblom D; Brodin LA; Islam KB
    Coron Artery Dis; 2001 May; 12(3):239-43. PubMed ID: 11352080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy.
    Sarkar N; Rück A; Källner G; Y-Hassan S; Blomberg P; Islam KB; van der Linden J; Lindblom D; Nygren AT; Lind B; Brodin LA; Drvota V; Sylvén C
    J Intern Med; 2001 Nov; 250(5):373-81. PubMed ID: 11887971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.
    Losordo DW; Vale PR; Hendel RC; Milliken CE; Fortuin FD; Cummings N; Schatz RA; Asahara T; Isner JM; Kuntz RE
    Circulation; 2002 Apr; 105(17):2012-8. PubMed ID: 11980678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina.
    Grines CL; Watkins MW; Mahmarian JJ; Iskandrian AE; Rade JJ; Marrott P; Pratt C; Kleiman N;
    J Am Coll Cardiol; 2003 Oct; 42(8):1339-47. PubMed ID: 14563572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison.
    Rodrigo SF; van Ramshorst J; Beeres SL; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Schalij MJ; Bax JJ; Atsma DE
    Am Heart J; 2012 Nov; 164(5):771-8. PubMed ID: 23137509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs.
    Crottogini A; Meckert PC; Vera Janavel G; Lascano E; Negroni J; Del Valle H; Dulbecco E; Werba P; Cuniberti L; Martínez V; De Lorenzi A; Telayna J; Mele A; Fernández JL; Marangunich L; Criscuolo M; Capogrossi MC; Laguens R
    Hum Gene Ther; 2003 Sep; 14(14):1307-18. PubMed ID: 14503966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia.
    Vale PR; Losordo DW; Milliken CE; Maysky M; Esakof DD; Symes JF; Isner JM
    Circulation; 2000 Aug; 102(9):965-74. PubMed ID: 10961959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease.
    Giusti II; Rodrigues CG; Salles FB; Sant'Anna RT; Eibel B; Han SW; Ludwig E; Grossman G; Prates PR; Sant'Anna JR; Filho GF; Markoski MM; Nesralla IA; Nardi NB; Kalil RA
    Hum Gene Ther Methods; 2013 Oct; 24(5):298-306. PubMed ID: 23944648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease.
    Fuchs S; Dib N; Cohen BM; Okubagzi P; Diethrich EB; Campbell A; Macko J; Kessler PD; Rasmussen HS; Epstein SE; Kornowski R
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):372-8. PubMed ID: 16892433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of myocardial viability with (99m)Tc-sestamibi -gated SPET images in patients undergoing percutaneous transluminar coronary angioplasty.
    Tzonevska A; Tzvetkov K; Dimitrova M; Piperkova E
    Hell J Nucl Med; 2005; 8(1):48-53. PubMed ID: 15886754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
    van Ramshorst J; Bax JJ; Beeres SL; Dibbets-Schneider P; Roes SD; Stokkel MP; de Roos A; Fibbe WE; Zwaginga JJ; Boersma E; Schalij MJ; Atsma DE
    JAMA; 2009 May; 301(19):1997-2004. PubMed ID: 19454638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.
    Losordo DW; Schatz RA; White CJ; Udelson JE; Veereshwarayya V; Durgin M; Poh KK; Weinstein R; Kearney M; Chaudhry M; Burg A; Eaton L; Heyd L; Thorne T; Shturman L; Hoffmeister P; Story K; Zak V; Dowling D; Traverse JH; Olson RE; Flanagan J; Sodano D; Murayama T; Kawamoto A; Kusano KF; Wollins J; Welt F; Shah P; Soukas P; Asahara T; Henry TD
    Circulation; 2007 Jun; 115(25):3165-72. PubMed ID: 17562958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.
    Stewart DJ; Hilton JD; Arnold JM; Gregoire J; Rivard A; Archer SL; Charbonneau F; Cohen E; Curtis M; Buller CE; Mendelsohn FO; Dib N; Page P; Ducas J; Plante S; Sullivan J; Macko J; Rasmussen C; Kessler PD; Rasmussen HS
    Gene Ther; 2006 Nov; 13(21):1503-11. PubMed ID: 16791287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.
    Beeres SL; Bax JJ; Kaandorp TA; Zeppenfeld K; Lamb HJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Atsma DE
    Am J Cardiol; 2006 May; 97(9):1326-31. PubMed ID: 16635605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary autologous CD34+ stem cell therapy for intractable angina.
    Wang S; Cui J; Peng W; Lu M
    Cardiology; 2010; 117(2):140-7. PubMed ID: 20975266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac shock wave therapy improves myocardial perfusion and preserves left ventricular mechanics in patients with refractory angina: A study with speckle tracking echocardiography.
    Duque AS; Ceccon CL; Mathias W; Majesky JD; Gowdak LH; Sbano JCN; Cesar LAM; Abduch MC; Lima MSM; Dourado PMM; Cruz CBBV; Tsutsui JM
    Echocardiography; 2018 Oct; 35(10):1564-1570. PubMed ID: 29962073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.